Phase I Clinical Evaluation of a Synthetic Oligosaccharide-Protein Conjugate Vaccine against Haemophilus influenzae Type b in Human Adult Volunteers

Since 1989, we have been involved in the development of a vaccine against Haemophilus influenzae type b. The new vaccine is based on the conjugation of synthetic oligosaccharides to tetanus toxoid. Our main goals have been (i) to verify the feasibility of using the synthetic antigen and (ii) to sear...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Toraño, Gilda, Toledo, Maria E., Baly, Alberto, Fernandez-Santana, Violeta, Rodriguez, Francisco, Alvarez, Yunia, Serrano, Teresita, Musachio, Alexis, Hernandez, Ibis, Hardy, Eugenio, Rodríguez, Arlene, Hernandez, Hector, Aguilar, Aristides, Sánchez, Raydel, Diaz, Manuel, Muzio, Verena, Dfana, Jorgelina, Rodríguez, Maria C., Heynngnezz, Lazaro, Verez-Bencomo, Vicente
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology 2006
Témata:
Vaccine Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1563574/
https://ncbi.nlm.nih.gov/pubmed/16960118
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00144-06
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky